Ifosfamide Chemotherapy: Uses, Dosage, Side Effects & Guidelines

Key Points About Ifosfamide Chemotherapy

Ifosfamide is a chemotherapy drug used to treat various cancers, including testicular, ovarian, and certain types of sarcomas. It works by slowing or stopping the growth of cancer cells. Typically, it is administered by a healthcare professional through an intravenous (IV) infusion. Patients should be aware of potential side effects and consult their doctor before making any changes to their treatment plan.

Names of Ifosfamide Medication

US Brand Name: Ifex

Generic Name: Ifosfamide

The generic name refers to the active ingredient in the medication, which is listed in parentheses next to the brand name.

Ifosfamide Pharmacologic Category

Category: Alkylating Agent

Ifosfamide belongs to a class of chemotherapy drugs known as alkylating agents. Other medications in this category include cyclophosphamide and melphalan.

Ifosfamide Dosage and Treatment Guidelines

Ifosfamide is prescribed to treat several types of cancer. The dosage and duration of treatment depend on the specific condition being treated. Always consult your healthcare provider before adjusting your dose. If you have any questions about your treatment, you can schedule a telemedicine appointment with one of our providers.

Ifosfamide Dosage for Testicular Cancer

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 weeks.

Length of Treatment: Typically 3 to 4 cycles, depending on the response to treatment.

Ifosfamide Dosage for Ovarian Cancer

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 to 4 weeks.

Length of Treatment: Varies based on the patient’s response and overall health.

Ifosfamide Dosage for Sarcoma

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 weeks.

Length of Treatment: Typically 4 to 6 cycles.

Ifosfamide Dosage for Lymphoma (Hodgkin’s and Non-Hodgkin’s)

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 to 4 weeks.

Length of Treatment: Varies depending on the type and stage of lymphoma.

Ifosfamide Dosage for Bladder Cancer

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 weeks.

Length of Treatment: Typically 4 to 6 cycles, depending on the response to treatment.

Ifosfamide Dosage for Neuroblastoma

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 to 4 weeks.

Length of Treatment: Varies based on the patient’s response and overall health.

Ifosfamide Dosage for Wilms Tumor

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 weeks.

Length of Treatment: Typically 4 to 6 cycles, depending on the response to treatment.

Ifosfamide Dosage for Ewing’s Sarcoma

Dosage: 1.2 grams per square meter (g/m²) of body surface area per day, administered over 5 consecutive days.

Frequency: Every 3 weeks.

Length of Treatment: Typically 4 to 6 cycles, depending on the response to treatment.

Ifosfamide Dosage Forms and Strengths

Injection: 1 gram per vial (powder for reconstitution)

Injection: 3 grams per vial (powder for reconstitution)

Ifosfamide Administration Guidelines

Ifosfamide is administered by a healthcare professional through an intravenous (IV) infusion, typically in a hospital or clinic setting. The infusion may take several hours, and you may receive additional medications to help prevent side effects such as nausea or bladder irritation. Staying well-hydrated during treatment and following your healthcare provider’s instructions is essential.

Ifosfamide Contraindications

A contraindication is a specific situation where a medication should not be used because it may cause harm. Ifosfamide has several contraindications that your healthcare provider will consider before prescribing this medication.

Allergy to Ifosfamide: If you have a known allergy to Ifosfamide or any of its components, you should not take this medication. An allergic reaction could cause serious symptoms such as rash, swelling, or difficulty breathing.

Severe Kidney Dysfunction: If you have severe kidney problems, Ifosfamide may not be safe for you. This medication is processed through the kidneys, and impaired kidney function can lead to higher drug levels in your system, increasing the risk of side effects.

Severe Liver Dysfunction: Ifosfamide is metabolized by the liver. If your liver is not functioning properly, the medication may not be broken down effectively, leading to potential toxicity.

Bone Marrow Suppression: If you have a history of bone marrow suppression or low blood cell counts, Ifosfamide may worsen this condition, leading to serious complications such as infections or bleeding.

If you have any of these conditions, it’s important to discuss them with your healthcare provider. If you’re unsure, one of our telemedicine providers can help you determine if Ifosfamide is the right treatment for you.

Drug to Drug Interactions

Ifosfamide can interact with other medications, potentially increasing side effects or reducing the effectiveness of either drug. It’s important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements.

Warfarin (Coumadin): Ifosfamide may enhance the effects of blood thinners like warfarin, which can increase the risk of bleeding.

Phenytoin (Dilantin): Ifosfamide can lower the levels of phenytoin in your blood, reducing its ability to control seizures.

Cisplatin (Platinol): When used together, cisplatin and Ifosfamide may increase the risk of kidney damage.

Amphotericin B (Fungizone): Combining these two drugs may heighten the risk of kidney toxicity.

Live Vaccines: Ifosfamide can weaken your immune system, making live vaccines (such as MMR or varicella) less effective and increasing your risk of infection.

If you are taking any of these medications, your healthcare provider may need to adjust your treatment plan. You can also consult one of our telemedicine providers to ensure you’re on the safest regimen possible.

Ifosfamide in Pregnancy

Is it Safe to Take Ifosfamide During Pregnancy?

Ifosfamide is not considered safe during pregnancy. It is classified as Pregnancy Category D, meaning there is evidence of fetal risk based on human data. Ifosfamide can harm an unborn baby, potentially causing birth defects or miscarriage. If you are pregnant or planning to become pregnant, discuss alternative treatments with your healthcare provider. If you’re unsure, one of our telemedicine providers can help you explore your options.

Ifosfamide While Breastfeeding

Is it Safe to Take Ifosfamide While Breastfeeding?

Ifosfamide is not recommended while breastfeeding, as it can pass into breast milk and may harm a nursing infant. If you are breastfeeding or plan to, talk to your healthcare provider about alternative treatments. You can also consult one of our telemedicine providers to find the safest option for you and your baby.

Estimated Cost of Ifosfamide

The cost of a 30-day supply of Ifosfamide without insurance can vary. With a GoodRX coupon, the estimated price ranges from $500 to $1,000, depending on dosage and pharmacy location. Check with your pharmacy for the most accurate pricing.

Possible Alternatives to Ifosfamide

If Ifosfamide is not suitable for you, alternative treatments or lifestyle changes may be available for the conditions it treats. Always discuss these alternatives with your healthcare provider before making any changes to your treatment plan. You can also consult one of our telemedicine providers to explore these options.

1. Testicular Cancer: Alternatives may include other chemotherapy agents like cisplatin or carboplatin. Surgery and radiation therapy are also potential options depending on the stage of the cancer.
2. Ovarian Cancer: Carboplatin and paclitaxel are commonly used alternatives. Targeted therapies like bevacizumab (Avastin) may also be considered.
3. Sarcoma: Doxorubicin and dacarbazine are alternative chemotherapy drugs. Surgery and radiation may also be part of the treatment plan.
4. Lymphoma: For Hodgkin’s lymphoma, alternatives include ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, dacarbazine). For non-Hodgkin lymphoma, rituximab (Rituxan) and CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) are common alternatives.
5. Bladder Cancer: Cisplatin-based chemotherapy, immunotherapy, and surgery are potential alternatives.
6. Neuroblastoma: Cyclophosphamide and topotecan are alternative chemotherapy agents. Surgery and radiation may also be considered.
7. Wilms Tumor: Vincristine and dactinomycin are commonly used alternatives. Surgery and radiation therapy may also be part of the treatment plan.
8. Ewing’s Sarcoma: Vincristine, doxorubicin, and cyclophosphamide are alternative chemotherapy agents. Surgery and radiation therapy may also be considered.
9. Hodgkin’s Lymphoma: ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, dacarbazine) is a common alternative to Ifosfamide.
10. Non-Hodgkin Lymphoma: Rituximab (Rituxan) and CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) are common alternatives.

Recent Updates on Ifosfamide Research

Recent studies are focused on optimizing Ifosfamide dosing and administration to reduce side effects while maintaining its effectiveness. Researchers are also exploring its use in combination with newer targeted therapies and immunotherapies to improve outcomes for patients with resistant or recurrent cancers. Additionally, ongoing clinical trials are investigating Ifosfamide in pediatric cancers, including neuroblastoma and Wilms tumor, to better understand its safety and efficacy in younger populations.

As research evolves, staying informed about the latest developments is crucial. If you have questions about how new research may affect your treatment plan, our telemedicine providers are available to discuss your options.

James Kingsley

Learn More